Arginase II inhibitory activity of flavonoid compounds from 
             by unknown
RESEARCH ARTICLE
Arginase II inhibitory activity of flavonoid compounds
from Scutellaria indica
Sang Won Kim • To Dao Cuong • Tran Manh Hung •
Sungwoo Ryoo • Jeong Hyung Lee •
Byung Sun Min
Received: 5 February 2013 / Accepted: 8 April 2013 / Published online: 20 April 2013
 The Author(s) 2013. This article is published with open access at Springerlink.com
Abstract Arginase II has recently reported as a novel
therapeutic target for the treatment of cardiovascular dis-
eases such as atherosclerosis. In the course of screening
plants used in natural medicines as arginase II inhibitory
activity, a methanol extract of Scutellaria indica showed
significant inhibitory effect. Further fractionation and
repeated column chromatography led to the isolation of a
new flavan-type (1), and seven known compounds (2–8).
The chemical structures of isolated compounds were elu-
cidated based on extensive 1D and 2D NMR spectroscopic
data. The isolates 1–8 were investigated in vitro for their
arginase II inhibitory activity using enzyme solution pre-
pared from kidney of anesthetized C57BL/6 mice. Com-
pounds 3 and 5 significantly inhibited arginase II activity
with IC50 values of 25.1 and 11.6 lM, respectively,
whereas the other compounds were apparently inactive.
Keywords Scutellaria indica  Labiatae  Flavonoid 
Arginase II inhibitory activity
Introduction
Arginine is the common substrate for both arginase and
nitric oxide synthase (NOS). Arginase hydrolyses arginine
to ornithine and urea, whereas NOS converts arginine to
nitric oxide (NO) and citrulline. In the wound and
elsewhere, arginase expression regulates arginine bio-
availability for NO synthesis. Arginase is present in two
isoforms as arginase I, the hepatic isoform, and arginase II,
the extrahepatic isoform, each of which is encoded by a
distinct gene. Arginase activation/upregulation results in
arginase/NOS imbalance, decrease NO production, and
contributes to endothelial dysfunction in a number of
pathophysiological processes such as aging (Berkowitz
et al. 2003) diabetes (Bivalaqua et al. 2001), hypertension
(Demougeot et al. 2005; Johnson et al. 2005) and athero-
sclerosis (Ryoo et al. 2006, 2008). Additionally, arginase
enhances production of reactive oxygen species by eNOS.
Arginase inhibition in hypercholesterolemic (ApoE(-/-))
mice or arginase II deletion (ArgII(-/-)) mice restores
endothelial vasorelaxant function, reduces vascular stiff-
ness, and markedly reduces atherosclerotic plaque burden.
Furthermore, arginase activation contributes to vascular
changes including polyamine-dependent vascular smooth
muscle cell proliferation and collagen synthesis. Collec-
tively, arginase may play a key role in the prevention and
treatment of atherosclerotic vascular disease (Ryoo et al.
2011a, b).
To search for new type of arginase II inhibitors, hun-
dreds of plant extracts were screened for activity against
arginase II, and a methanol extract of S. indica was found
to inhibit arginase II. S. indica (Labiatae) is a small herb,
with erect stems arising from a prostrate base, and usually
15–30 cm tall. The plant often has a main stem and several
side branches. The whole herb of S. indica, known as
‘‘Han-xin-cao,’’ is used for treatment of hemoptysis,
hematemesis, anticancer, and other disease in China and is
distributed widely in Korea, China, Taiwan, Japan, and
Southeast Asia (Chiang Su New Medical College 1977).
The methanolic extraction of the root of S. indica was
found to have potent cytotoxic activity against L1210 and
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HL60 cells in an earlier in vitro screening test (Bae et al.
1994). Bae et al. confirmed that an ether extract of S. indica
with flavonoid compounds has potent inhibition of cyto-
toxic effects (Bae et al. 1994), but its chemical composition
and biological evaluation have not yet been performed
thoroughly in regard to the inflammatory activity of this
plant. Therefore, to investigate inhibitors of arginase II,
further fractionation of the EtOAc-soluble fraction resulted
in the isolation of a new compound, along with seven
known compounds. This study describes the isolation and




Optical rotation was measured with a JASCO DIP 370
digital polarimeter. UV spectra were obtained in MeOH
using a Thermo 9423AQA2200E UV spectrometer, and IR
spectra were obtained on a Bruker Equinox 55 FT-IR
spectrometer. The nuclear magnetic resonance (NMR)
spectra were obtained on varian unity inova 400 MHz
spectrometer. ECD spectra were recorded on a JASCO
J-810 spectropolarimeter. EI-MS and HR-EI-MS spectro-
metric data were acquired with a JMS-700 MSTATION
mass spectrometer (JEOL, Japan). Silica gel (Merck,
63–200 lm particle size) and RP-18 silica gel (Merck,
75 lm particle size) were used for column chromatogra-
phy. TLC was carried out using Merck silica gel 60 F254
and RP-18 F254 plates. HPLC was performed using a
Waters 600 Controller system with a UV detector and an
YMC Pak ODS-A column (20 9 250 mm, 5 lm particle
size, YMC Co., Ltd., Japan) and HPLC solvents were from
Burdick & Jackson, USA.
Plant material
S. indica was collected in Jindo island, Korea, in May
2011. Botanical identification was performed by Prof.
Byung-Sun Min, and the voucher specimen CUD-1523 was
deposited at the herbarium of the College of Pharmacy,
Catholic University of Daegu, Korea.
Extraction and isolation
The air-dried whole plant of S. indica (3.09 kg) was
extracted with MeOH (15 L) at room temperature for
7 days and then MeOH extract (408.9 g) was suspended in
hot-water (2 L) and partitioned with n-hexane (3 L 9 3),
ethyl acetate (3 L 9 3), and n-butanol (3 L 9 3), succes-
sively. The resulting fractions were concentrated in vacuo
to give the hexane- (179.3 g), EtOAc- (62.0 g) and BuOH-
soluble fraction (26.8 g), respectively. By the activity-
guided fractionation, the EtOAc-soluble fraction (62.0 g)
was applied to a silica gel column eluted with CHCl3–
MeOH (50:1 to 0:1) to yielded 15 subfractions
(E1 * E15). Subfraction E6 (1.85 g) was subjected on a
silica gel column, eluted with hexane–acetone (15:1 to 5:1)
to afford nine subfractions (E6.1 * E6.9). Compound 1
(14.3 mg) was crystallized from subfraction E6.2
(328.4 mg) with hexane–acetone (10:1). Subfraction E6.5
(508.4 mg) was applied on a reverse phase silicagel col-
umn and eluted MeOH–H2O (1:1 to 5:1) to afford four
subfraction (E6.5.1 * 6.5.4). Subfractions E6.5.2
(125.0 mg) was subjected to HPLC using MeOH–H2O
(1:1 * 4:1) to obtain compound 2 (20.2 mg). Subfraction
E6.5.4 (114.0 mg) was subjected to HPLC using MeOH–
H2O(1:1 * 3:1) to obtain compound 3 (35.0 mg). Sub-
fraction E6.6 (1.3 g) subjected to MPLC using MeOH–
H2O (2:1) to furnish compound 5 (151 mg). Subfraction
E.9 (1.65 g) was applied to a reverse phase silica gel col-
umn and eluted with MeOH–H2O (1:1 to 5:1) to afford
three subfractions (E9.1 * E9.5). Compounds 4 (8.3 mg)
and 6 (151.0 mg) were isolated from subfraction E9.3 by
using HPLC on a RP-18 column using MeOH–H2O (70 :
30 ? 100 : 0). Subfractions E12 (7.22 g) was subjected on
a silica gel column, eluted with CHCl3–MeOH (10:1 to
1:1) to afford nine subfractions (E12.1 * E12.9). Sub-
fraction E.12.2 (158.8 mg) was further subjected to HPLC
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Fig. 1 Chemical structure of isolated compounds 1–8
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to obtain compounds 7 (3.6 mg) and 8 (5.7 mg), respec-
tively (Fig. 1)
(2R,4S)-4,5,6,7,8,40-hexamethoxylflavanone (1): white
crystal; m.p: 218–220 C; [a] ?14.7 (c 0.42, MeOH); UV
(CHCl3) kmax nm: 209, 282; CD (c 0.15, MeOH): De208
(nm) ?1.95; De229 (nm) -7.84; HR-EI-MS m/z: 390.1679
[M]? (calcd. for C21H26O7);
1H NMR (400 MHz in
CD3OD) and
13C NMR (100 MHz in CD3OD) spectro-
scopic data, see Table 1.
Arginase II
Arginase II solution was prepared from kidney lysates of
anesthetized C57BL/6 mice (White et al. 2006). Tissue
lysates of kidney were prepared using lysis buffer (50 mM
Tris–HCl, pH7.5, 0.1 mM EDTA and protease inhibitors)
by homogenization at 4 C followed by centrifugation for
20 min at 14,0009g at 4 C. Briefly, aortic lysates were
added to Tris–HCl. The hydrolysis reaction of L-arginine
by Arg was performed by incubating the mixture contain-
ing activated Arg and was stopped by adding acid solution.
For calorimetric determination of urea, a-isonitrosopropi-
ophenone was added, and the mixture was heated at 100 C
for 45 min. After placing the sample in the dark for 10 min
at room temperature, the urea concentration was
determined spectrophotometrically by the absorbance at
550 nm (White et al. 2006).
Results and discussion
The MeOH extract of S. indica was partitioned into
n-hexane-, EtOAc-, and n-BuOH-soluble fractions and a
H2O layer. Chromatographic purification of the EtOAc-
soluble fraction led to the isolation of eight compounds.
The structures of known compounds were identified as
wogonin (2) (Li et al. 2009), (2S)-5,7-dihydroxy-8,20-di-
methoxyflavanone (3) (Tomimori et al. 1985), apigenin (4)
(Loo et al. 1986), (2S)-5,20,50-trihydroxy-7,8-dimethoxyf-
lavanone (5) (Miyaichi et al. 1987), naringenin (6), na-
ringenin-5-O-b-D-glucopyranoside (7) (Ibrahim et al. 2003)
and (2S)-5,50-dihydroxy-7,8-dimethoxyflavanone-20-O-b-
D-glucopyranoside (8) (Botha et al. 1981) by comparing
their physiochemical and spectroscopic data with those
reported in the literature (Fig. 1).
Compound 1 was isolated as a white crystal, with the
molecular formula C21H26O7, as determined by the HR-EI-
MS at m/z 390.1679 for the [M]? ion (calculated for
C21H26O7, 390.1678). The optical rotation value was
?14.7, and the UV spectrum exhibited kmax at 209 and
282 nm (MeOH). In accordance with the molecular for-
mula, 21 carbon signals in the 13C-NMR spectrum of 1
were categorized as four sp2 methines, eight sp2 quater-
nary, six methoxyls, one sp3 methylene and two sp3
methines carbons. Apart from the six methoxyls, the
remaining 15 carbons comprising its scaffold as one C6–
C3–C6 unit with two benzene rings suggested that 1 was a
flavanoid skeleton. The 1H-NMR spectrum of 1 showed six
methoxyl signals at dH 3.52–3.94 (18H, s), and this infor-
mation indicated that 1 has a hexasubstituted in two
Table 1 1H NMR (400 MHz, CD3OD) and
13C NMR (100 MHz,
CD3OD) spectroscopic data for compound 1
Position 1
dH (ppm) dC (ppm)
2 5.07 (1H, dd, J = 2.4, 12.4 Hz) 74.5
3 2.37 (1H, dt, J = 2.4, 14.4 Hz) 35.1
1.89 (1H, ddd, J = 2.4, 14.4, 12.4 Hz)








20, 60 7.42 (2H, d, J = 8.8 Hz) 128.9
30, 50 6.98 (2H, d, J = 8.8 Hz) 115.0
40 161.2
4-OCH3 3.52 (3H, s) 56.6
5-OCH3 3.94 (3H, s) 62.1
6-OCH3 3.85 (3H, s) 61.8
7-OCH3 3.92 (3H, s) 62.0
8-OCH3 3.78 (3H, s) 61.7
40-OCH3 3.83 (3H, s) 55.9
Table 2 Arginase II inhibitory activity of compounds 1–8




3 25.1 ± 2.6
4 [200




PGb 1.0 ± 0.1
a The inhibitory effects are represented as the molar concentration
(lM) giving 50 % inhibition (IC50) relative to the vehicle control.
These data represent the average values of three repeated experiments
b Piceatannol-30-O-b-D-glucopyranoside (PG) was used as positive
control
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benzene rings. Furthermore, a typical AA0BB0 spin system
at dH 7.42 (d, J = 8.8 Hz, H-20,60) and 6.98 (d,
J = 8.8 Hz, H-30,50) was also observed. The characteristic
signals of a flavan moiety as a AB2C coupling system at dH
5.07, 2.37, 1.89 and 4.56 were observed in the 1H-NMR
spectrum of 1, indicating that 1 might have a flavan part
(Table 1). The presence of the flavan part was further
confirmed by correlations of dH 5.07 (H-2) to dC 35.1
(H-3), 128.9 (C-20, 60) and 134.6 (C-10); dH 4.56 (H-4) to dC
74.5 (C-2), 35.1 (C-3), 146.5 (C-8a), 113.3 (C4a) and 149.6
(C-5) in the HMBC experiment (Fig. 2). The positions of
six methoxyl groups were determined based on the HMBC
and NOESY spectra. In the HMBC spectrum, the long-
range correlation between signals were observed at dH 3.83
(3H, s) and dC 161.2; dH 3.52 (3H, s) and dC 69.9; dH 3.94
(3H, s) and dC 149.6; dH 3.85 (3H, s) and dC 141.1; dH 3.92
(3H, s) and dC 149.4; dH 3.78 (3H, s) and dC 139.2. From
the NOESY spectrum, the protons at dH 3.83 (3H, s) dis-
played NOEs with the aromatic proton signals at dH 6.98
(H-20, 50), and the methoxyl at dH 3.52 (3H, s) displayed
NOEs with the methoxyl protons at dH 3.94 (3H, s). Fur-
thermore, the methoxyl proton signal at dH 3.85 (3H, s)
also displayed NOEs with the methoxyl proton signals at
dH 3.94 (3H, s) and 3.92 (3H, s), and the methoxyl proton
signal at dH 3.78 (3H, s) displayed NOEs with the methoxyl
proton at dH 3.92 (3H, s), indicating that these methoxyl
groups were located C-40, C-4, C-5, C-6, C-7, and C-8. In
addition, both H-2 and H-4 showed connectivity to
H-3a and H-3e in the 1H–1H correlation spectroscopy
(COSY) spectrum of compound 1 (Fig. 2).
The stereochemistry of compound 1 was defined on the
basis of its nuclear Overhauser effect spectroscopy (NO-
ESY) spectrum. NOE correlation was observed between
H-2 and H-3a, while H-4 exhibited NOEs to H-3e. These
results were in agreement with the relative stereochemistry,
which was further confirmed by the coupling constant
and split pattern. The coupling constants of the spin sys-
tems in the 1H NMR spectrum of 1 [J2,3a = 12.4 Hz;
J2,3e = 2.4 Hz] indicated indicated H-2 retain as an axial
bond (Botha et al. 1981). An S absolute configuration of
compound 1 at C-4 was realized by a positive Cotton effect
of De208 ?1.95 and a negative Cotton effect of De229 -7.84
(Barrett et al. 1979). Therefore, it was presumed that
compound 1 possessed a 2R,4S absolute configuration.
Herein, the structure of compound 1 was established as
(2R,4S)-4,5,6,7,8,40-hexamethoxylflavan.
Arginase II activity is upregulated in atherosclerosis-
prone mice, and is associated with impaired endothelial NO
production, endothelial dysfunction, vascular stiffness, and
ultimately, aortic plaque development. Conversely, inhib-
iting endothelial arginase or deleting the arginase II gene
enhances NO production, restores endothelial function and
aortic compliance, and reduces plaque burden. Therefore,
arginase II represents a novel target for preventing and
treating atherosclerotic vascular disease (Ryoo et al. 2008).
In the present study, we screened the isolated compounds
for anti-arginase II activity. The results showed that incu-
bating compounds 3 and 5 from kidney lysates significantly
inhibited arginase II activity with IC50 values of 25.1 and
11.6 lM, respectively, whereas the other compounds were
apparently inactive (Table 2). In this study, piceatannol-30-
O-b-D-glucopyranoside (PG), was used as positive control
(Woo et al. 2010), showed an IC50 value of 1.0 lM.
Although the inhibitory potency of 3 and 5 against arginase
II activity are higher compared to PG, the identification of
new moiety from natural medicinal plants that inhibits
arginase activity would be useful for the development of
pharmaceutical natural compounds.
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